Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenrise Global Brands is a Canadian-based investment company focused on the medical cannabis market in Germany. Through its wholly-owned subsidiary, AMP Alternative Medical Products GmbH, the company imports and distributes a diverse portfolio of EU-GMP compliant medical cannabis products, including dried flowers and extracts. The company serves as a bridge between international cannabis producers and the German pharmaceutical market, supplying pharmacies and healthcare providers with cannabinoid-based therapies. Greenrise Global Brands emphasizes quality control and regulatory compliance to meet the stringent requirements of the German healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greenrise Global Brands.